Építés alatt – nem éles oldal
Belépés

What researchers published on Follikuláris limfóma

3595 papers, newest first.

Showing 40 of 3595

  • MetaanalízisLenalidomide and rituximab for relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.Blood cancer journal
  • Spatial and transcriptomic analyses reveal the adverse prognostic impact of regulatory T cells in follicular lymphoma treated with rituximab-lenalidomide.British journal of haematology
  • EsetismertetésFollicular Lymphoma Presenting as Refractory Panniculitis-like Lesions: A Case Report of Successful Salvage with Autologous Stem Cell Transplantation.Journal of clinical medicine
  • EsetismertetésConcurrent splenic infarction and pulmonary embolism as the initial presentation of high-grade follicular lymphoma: a case report.Frontiers in oncology
  • Pediatric-type Follicular Lymphoma Shows Unique Immunogenetic Features With Lack of Acquired N-glycosylation Sites.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • Et tu, CD70? When friend turns foe for follicular lymphoma.Blood
  • Outcomes for Patients With Primary Gastrointestinal Follicular Lymphoma: Results From a Multicenter Analysis.Cancer medicine
  • Beyond PET/CT: the evolving role of circulating tumor DNA in follicular lymphoma.Frontiers in immunology
  • Beyond the plateau: defining cure and charting the next decade in follicular lymphoma: redefining cure in follicular lymphoma.Medical oncology (Northwood, London, England)
  • Áttekintés[Treatment strategies for lymphoma in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • ÁttekintésLow tumor burden follicular lymphoma: The state of the art.HemaSphere
  • Prognostic value of cell differentiation-related genes in follicular lymphoma based on integrated single-cell and bulk RNA sequencing.Neoplasma
  • EsetismertetésPersistent Campylobacter jejuni enterocolitis after CAR T-cell therapy in a patient with hypogammaglobulinemic follicular lymphoma.ASM case reports
  • EsetismertetésLower Back Pain As the Initial Manifestation of Primary Follicular B-cell Non-Hodgkin Lymphoma of the Bone Marrow: A Case Report.Cureus
  • Follicular Lymphoma: 2027 Annual Update.American journal of hematology
  • Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma: Final Analysis of the Phase 2 ROSEWOOD Study.Targeted oncology
  • Baseline maximum standardised uptake value does not predict outcomes in high-tumour-burden follicular lymphoma treated with first-line immunochemotherapy.British journal of haematology
  • Esetismertetés[Composite follicular lymphoma and mantle cell lymphoma: report of a case].Zhonghua bing li xue za zhi = Chinese journal of pathology
  • Assessment of BCL-2 expression in bone marrow by flow cytometry to aid in the diagnosis and differential diagnosis in patients with follicular lymphoma.Cytometry. Part B, Clinical cytometry
  • Comparative survival and time toxicity outcomes of CAR-T versus bispecific antibody therapies in relapsed/refractory FL.Blood advances
  • Áttekintés[Treatment strategies and future perspectives in follicular lymphoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Obinutuzumab and Chemotherapy for Front-Line Treatment of Follicular Lymphoma Grade 3B and Composite Follicular Lymphoma: A Study of the Croatian Cooperative Group for Hematologic Diseases (KroHem).Pharmaceuticals (Basel, Switzerland)
  • Navigating T-Cell-Directed Therapies in Transformed Follicular Lymphoma.Cancers
  • Clinical Characteristics, Progression of Disease Within 24 Months (POD24), and Real-World Outcomes of Follicular Lymphoma in Saudi Arabia: A Two-Centre Retrospective Analysis.Cancers
  • Adjusted Indirect Comparison Between Epcoritamab-R2 and Tafasitamab-R2 in Relapse/Refractory Follicular Lymphoma.Hematological oncology
  • CAR-HEMATOTOX score to predict risk of poor outcomes with odronextamab in heavily pretreated B-cell non-Hodgkin lymphoma.British journal of haematology
  • Newly diagnosed and relapsed follicular lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.HemaSphere
  • Capsule retention revealing systemic follicular lymphoma with small-bowel involvement.Gastroenterologia y hepatologia
  • Real-world outcomes of mosunetuzumab use in relapsed/refractory indolent lymphomas: a CUBIC consortium analysis.Blood neoplasia
  • EZH2 mutation status predicts inferior outcomes after bendamustine-based immunochemotherapy in frontline follicular lymphoma: A GELTAMO multicenter validation study.HemaSphere
  • Intrafollicular PAI-1 Expression Is Associated with Absence of Histological Transformation During Long-Term Follow-Up in Follicular Lymphoma.International journal of molecular sciences
  • Immunohistochemical Classification and Prognostic Significance of Germinal Center-like and Memory Cell-like Subtypes of Follicular Lymphoma Using FOXP1, LMO2, CD22, and MUM1.International journal of molecular sciences
  • Efficacy and safety of lisocabtagene maraleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: 31-month follow-up of the phase 2 TRANSCEND FL study.International journal of clinical oncology
  • EsetismertetésPersistent multifocal pulmonary consolidations in a young adult: An unusual presentation of primary pulmonary follicular lymphoma.Respiratory medicine case reports
  • ÁttekintésAdvances in CAR-T and CAR-NK Cell Therapy in Follicular Lymphoma: A Review.Transplantation and cellular therapy
  • [Clinical characteristics of acute thrombocytopenia in newly diagnosed follicular lymphoma patients receiving obinutuzumab chemotherapy].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • CAR T-cell therapy for relapsed and refractory B-cell non-Hodgkin lymphoma: a single-centre 5-year real-world experience study at Ghent University Hospital.Acta clinica Belgica
  • A tale of two triplets: tafasitamab or epcoritamab in combination with rituximab and lenalidomide in relapsed/refractory follicular lymphoma.Expert opinion on biological therapy
  • MetaanalízisRituximab Versus Watchful Waiting for Asymptomatic Advanced-Stage Low-Tumor-Burden Follicular Lymphoma: A Systematic Review and Meta-Analysis.Clinical lymphoma, myeloma & leukemia
  • FDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma.Clinical cancer research : an official journal of the American Association for Cancer Research